Cargando…
COVID-19 in Nigeria: Is the pharmaceutical sector spared?
Autores principales: | Akande-Sholabi, Wuraola, Adebisi, Yusuff Adebayo, Bello, Ayomide, Ilesanmi, Olayinka Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553864/ https://www.ncbi.nlm.nih.gov/pubmed/34173578 http://dx.doi.org/10.1016/j.puhip.2020.100044 |
Ejemplares similares
-
The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2020) -
Extent of misuse and dependence of codeine-containing products among medical and pharmacy students in a Nigerian University
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2019) -
When it is available, will we take it? Social media users’ perception of hypothetical COVID-19 vaccine in Nigeria
por: Adebisi, Yusuff Adebayo, et al.
Publicado: (2021) -
Drug take-back program: assessment of knowledge, practices, and barriers to safe disposal of unused medication among healthcare students in a Nigerian university
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023) -
Antimicrobial stewardship: knowledge, perceptions, and factors associated with antibiotics misuse among consumer’s visiting the community pharmacies in a Nigeria Southwestern State
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)